EJNMMI Radiopharmacy and Chemistry

eISSN: 2365-421X pISSN: 2365-421X

Aims and Scope

EJNMMI Radiopharmacy and Chemistry publishes new research in the field of development of new imaging and radionuclide-based therapeutic agents for application in nuclear medicine and molecular imaging. The journal provides a platform for chemists, pharmacists and basic scientists to present their views and scientific work. In addition, the journal provides insight into novel concepts of imaging or radionuclide-based therapeutic agent applications of relevance for the whole molecular imaging community. The journal reports original research articles, review papers, guidelines on the application of imaging or radionuclide therapy agents, editorials, and letters to the editor. Research articles on novel radiochemistry, new radiopharmaceuticals including their first biological evaluation, molecular imaging agents including optical imaging, MRI, and hybrid probes, are the main focus of the journal. To translate imaging and radionuclide therapy agents to the clinic, legislative issues related to their production and safety can be presented as well in theÂ form of guidelines or position papers.

Key Metrics

2

CiteScore

2 Mo

Time to Publish

Time To Publish

% of papers by time taken from submission to publication

0 to 3 months

83%

4 to 6 months

15%

7 to 9 months

1%

Above 9 months

0%

Did you find this useful?

Thank you for your feedback.

Topics Covered

Positron emission tomography
HEPES
Room temperature
Breast cancer
Cell binding
Quality control
Editorial board
Pet tracer
Radioimmunotherapy
Panitumumab
Radionuclide
Pet imaging
Aqueous solution
Normal tissue toxicity
Scid mice
Scandium
Boronic acid
Adoptive Cell Transfer Therapy
Isotope exchange
Tumor cell death

Journal Specifications

Overview
Publisher	Springer Nature
Language	English
Frequency	Continuous publication
Article Processing Charges	GBP 1190 \| USD 1890
Publication Time	5
Editorial Review Process	Blind peer review
General Details
Language	English
Society/Institute/Sponsor	European Association of Nuclear Medicine (EANM)
Frequency	Continuous publication
Publisher URL	Visit website
Website URL	Visit website
Publication Details
Plagiarism	Visit website
Waiver Policy	Visit website
Publication Time	5
Article Processing Charges	GBP 1190 \| USD 1890
Editorial Review Detail
Editorial Team	Visit website
Review Process	Blind peer review
Review Url	Visit website
Information for authors
Author instructions	Visit website
Copyright Details	Visit website
Deposit Policy	Sherpa/Romeo
License type	CC BY
OA statement	Visit website

Planning to publish in EJNMMI Radiopharmacy and Chemistry ?

Upload your Manuscript to get

Degree of match
Common matching concepts
Additional journal recommendations

Check your researchless than 30 sec

Looking for the right journals to submit your mansucript?

Upload your manuscript and get a submission readiness score and other journal recommendations.

Check my Paper

Scite analysis

Powered by scite_

290 articles received 3.3k citations see all

73 Supporting
3,145 Mentioning
10 Contrasting

Editorial notices

0 Retractions
0 Withdrawals
5 Corrections
19 Errata
0 Expression of Concern

FAQs

What is the publishing frequency of EJNMMI Radiopharmacy and Chemistry ?

EJNMMI Radiopharmacy and Chemistry published with a Continuous publication frequency.

What is the eISSN & pISSN for EJNMMI Radiopharmacy and Chemistry ?

For EJNMMI Radiopharmacy and Chemistry,eISSN is 2365-421X and pISSN is2365-421X.

What is Citescore for EJNMMI Radiopharmacy and Chemistry ?

Citescore for EJNMMI Radiopharmacy and Chemistry is 2.

Who is the publisher of EJNMMI Radiopharmacy and Chemistry ?

Springer Nature is the publisher of EJNMMI Radiopharmacy and Chemistry.